Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5702
Peer-review started: May 30, 2019
First decision: July 21, 2019
Revised: July 30, 2019
Accepted: September 9, 2019
Article in press: September 9, 2019
Published online: October 7, 2019
Processing time: 124 Days and 10.5 Hours
Irritable bowel syndrome (IBS) is a prevalent and debilitating gastrointestinal condition. Research has reported persistent, low-grade mucosal inflammation and significant overlaps between patients with IBS and those with dyspepsia, suggesting a possible pathogenic role of Helicobacter pylori (H. pylori) in IBS. This study therefore aimed to provide the first systematic review and meta-analysis on the association between H. pylori infection and IBS.
To investigate the association between H. pylori infection and IBS.
Using the keywords “H. pylori OR Helicobacter OR Helicobacter pylori OR infection” AND “irritable bowel syndrome OR IBS”, a preliminary search of PubMed, Medline, Embase, Cochrane Database of Systematic Reviews, Web of Science, Google Scholar and WanFang databases yielded 2924 papers published in English between 1 January 1960 and 1 June 2018. Attempts were also made to search grey literature.
A total of 13 clinical studies were systematically reviewed and nine studies were included in the final meta-analysis. Random-effects meta-analysis found a slight increased likelihood of H. pylori infection in patients with IBS, albeit this was not statistically significant (pooled odds ratio 1.47, 95% confidence interval: 0.90-2.40, P = 0.123). It must also be acknowledged that all of the available studies reported only crude odd ratios. H. pylori eradication therapy also does not appear to improve IBS symptoms. Although publication bias was not observed in the funnel plot, there was a high degree of heterogeneity amongst the studies included in the meta-analysis (I2 = 87.38%).
Overall, current evidence does not support an association between IBS and H. pylori infection. Further rigorous and detailed studies with larger sample sizes and after H. pylori eradication therapy are warranted.
Core tip: This is the first systematic review to examine the association of Helicobacter pylori (H. pylori) infection and irritable bowel syndrome (IBS). 13 clinical studies were systematically reviewed and nine studies were included in the final meta-analysis. Random-effects meta-analysis suggests a tenuous association between the two (pooled odds ratio 1.47, 95% confidence interval: 0.90-2.40, P = 0.123). H. pylori eradication therapy also does not appear to improve IBS symptoms in the limited studies available. Further detailed trials with larger sample sizes and after H. pylori eradication therapy are necessary to elucidate the relationship between H. pylori infection and IBS pathogenesis.